| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CLPT
ClearPoint Neuro
|
Jun 17, 2026 | BUY |
Strong Buy
+13.7% avg upside
7 analysts
|
— | · |
|
NSPR
InspireMD
|
Jun 11, 2026 | BUY |
Strong Buy
+447.3% avg upside
8 analysts
|
$4.00
463.46% Upside
|
· |
|
AORT
Artivion
|
Jun 09, 2026 | BUY |
Strong Buy
+91.8% avg upside
8 analysts
|
$45.00
112.41% Upside
|
-2.6% |
|
NPCE
NeuroPace
|
May 29, 2026 | BUY |
Strong Buy
+12.2% avg upside
11 analysts
|
$20.00
27.99% Upside
|
-8.3% |
|
TLSI
TriSalus Life Sciences
|
May 29, 2026 | BUY |
Strong Buy
+126.7% avg upside
8 analysts
|
$8.00
96.13% Upside
|
· |
|
HYPR
Hyperfine
|
May 27, 2026 | BUY |
Strong Buy
+27.5% avg upside
6 analysts
|
$2.50
56.23% Upside
|
· |
|
DXR
Daxor
|
May 26, 2026 | BUY |
Strong Buy
+122.2% avg upside
6 analysts
|
$23.00
135.86% Upside
|
· |
|
BBNX
Beta Bionics, Inc.
|
May 22, 2026 | BUY |
Strong Buy
+51.9% avg upside
13 analysts
|
$20.00
44.14% Upside
|
+22.9% |
|
ADGM
Adagio Medical Holdings
|
May 21, 2026 | BUY |
Strong Buy
+414.7% avg upside
2 analysts
|
$4.00
488.22% Upside
|
-17.0% |
|
ELUT
Elutia
|
May 15, 2026 | BUY |
Strong Buy
+664.1% avg upside
5 analysts
|
$5.00
371.68% Upside
|
· |
|
CLBT
Cellebrite DI
|
May 15, 2026 | BUY |
Strong Buy
+51.2% avg upside
15 analysts
|
$21.00
63.63% Upside
|
-1.2% |
|
RCEL
Avita Medical
|
May 15, 2026 | BUY |
Strong Buy
+154.7% avg upside
10 analysts
|
$6.00
49.70% Upside
|
-1.8% |
|
STXS
Stereotaxis
|
May 13, 2026 | BUY |
Strong Buy
+126.1% avg upside
7 analysts
|
$4.00
112.84% Upside
|
-3.8% |
|
TELA
TELA Bio
|
May 13, 2026 | BUY |
Strong Buy
+1023.6% avg upside
8 analysts
|
$2.00
149.75% Upside
|
+3.1% |
|
SMTI
Sanara MedTech
|
May 13, 2026 | BUY |
Strong Buy
+76.2% avg upside
5 analysts
|
$32.00
45.24% Upside
|
+0.8% |
|
CVRX
CVRx
|
May 12, 2026 | BUY |
Strong Buy
+136.7% avg upside
9 analysts
|
$14.00
182.92% Upside
|
+15.9% |
|
LNSR
LENSAR
|
May 11, 2026 | BUY |
Strong Buy
+113.4% avg upside
4 analysts
|
$10.00
74.22% Upside
|
-0.7% |
|
TNDM
Tandem Diabetes Care
|
May 08, 2026 | BUY |
Strong Buy
+116.0% avg upside
29 analysts
|
$50.00
226.81% Upside
|
+9.2% |
|
KRMD
REPRO-MED Systems
|
May 07, 2026 | BUY |
Strong Buy
+65.0% avg upside
9 analysts
|
$8.00
105.09% Upside
|
-6.8% |
|
LTRX
Lantronix
|
May 07, 2026 | BUY |
Strong Buy
+29.9% avg upside
8 analysts
|
$8.00
20.54% Upside
|
+27.0% |
|
LMAT
Lemaitre Vascular
|
May 06, 2026 | BUY |
Strong Buy
+7.8% avg upside
15 analysts
|
$135.00
43.79% Upside
|
-16.5% |
|
LUNG
Pulmonx
|
Apr 30, 2026 | BUY |
Strong Buy
+321.4% avg upside
9 analysts
|
$4.00
212.46% Upside
|
+7.0% |
|
AXGN
AxoGen
|
Apr 28, 2026 | BUY |
Strong Buy
-25.7% avg upside
21 analysts
|
$50.00
11.57% Upside
|
+6.1% |
|
SGHT
Sight Sciences
|
Mar 30, 2026 | BUY |
Buy
+52.9% avg upside
13 analysts
|
$12.00
127.27% Upside
|
+33.4% |
|
MDXG
MiMedx Group
|
Feb 26, 2026 | BUY |
Strong Buy
+184.1% avg upside
17 analysts
|
$10.00
172.50% Upside
|
-27.0% |
|
IRMD
Iradimed
|
Feb 11, 2026 | BUY |
Strong Buy
-9.3% avg upside
6 analysts
|
$120.00
30.09% Upside
|
-15.6% |
|
NOTVQ
Inotiv
|
Feb 10, 2026 | BUY |
Strong Buy
+179210.3% avg upside
6 analysts
|
$1.50
10244.79% Upside
|
· |
|
AVR
Anteris Technologies Global Corp.
|
Jan 23, 2026 | BUY |
Strong Buy
+49.3% avg upside
5 analysts
|
$15.00
53.44% Upside
|
+51.4% |
|
ANGO
AngioDynamics
|
Jan 07, 2026 | BUY |
Strong Buy
+39.9% avg upside
9 analysts
|
$24.00
97.59% Upside
|
+7.5% |
|
COCH
Envoy Medical
|
Oct 07, 2025 | BUY |
Strong Buy
+909.5% avg upside
5 analysts
|
$6.00
846.41% Upside
|
-55.6% |
|
INSP
Inspire Medical Systems
|
Aug 27, 2025 | BUY |
Buy
+97.6% avg upside
20 analysts
|
$150.00
252.06% Upside
|
-54.2% |
|
APYX
Apyx Medical
|
Aug 09, 2024 | BUY |
Strong Buy
+613.1% avg upside
10 analysts
|
$2.50
39.27% Downside
|
+109.6% |
|
FOCL
EDAP TMS
|
Jul 22, 2024 | BUY |
Buy
+43.5% avg upside
7 analysts
|
$10.00
107.92% Upside
|
· |
|
PAVM
PAVmed
|
May 15, 2024 | BUY |
Strong Buy
+725.5% avg upside
5 analysts
|
$4.00
22.58% Downside
|
-66.8% |
|
TSE:PRN
Profound Medical
|
Nov 03, 2023 | BUY |
Strong Buy
+96.8% avg upside
11 analysts
|
$19.81
106.39% Upside
|
· |
|
BIOLQ
BIOLASE
|
May 31, 2023 | BUY |
Strong Buy
+1197999900.0% avg upside
6 analysts
|
$40.00
3999999899.95% Upside
|
· |
|
BTCY
Biotricity
|
Feb 14, 2023 | BUY |
Buy
+7767.4% avg upside
4 analysts
|
$12.00
9837.81% Upside
|
-78.7% |
|
CATX
Perspective Therapeutics
|
Sep 29, 2022 | BUY |
Strong Buy
+280.3% avg upside
22 analysts
|
$1.00
66.15% Downside
|
+22.7% |
|
OSUR
Orasure Technologies
|
May 11, 2022 | BUY |
Buy
+100.0% avg upside
11 analysts
|
$10.00
135.27% Upside
|
· |
|
TSE:PINK
Perimeter Medical Imaging AI
|
Apr 05, 2022 | BUY |
Strong Buy
+841.6% avg upside
4 analysts
|
$5.66
1818.90% Upside
|
· |
|
UPHL
UpHealth
|
Mar 31, 2022 | HOLD |
Strong Buy
+2683233.4% avg upside
6 analysts
|
$10.00
3333233.41% Upside
|
-87.4% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.